1. EachPod

ReachMD CME - Podcast

ReachMD CME

 ReachMD

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Health Medicine Science & Medicine
Update frequency
every day
Episodes
499
Years Active
2019 - 2025
Share to:
Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy

Expert Peer Discussion: Integrating Novel HER3-Directed ADCs Upon Disease Progression Following EGFR TKI and Platinum Chemotherapy

Tue 17 Dec 2024
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective

The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care – Chair’s Perspective

Tue 17 Dec 2024
Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy

Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy

Tue 17 Dec 2024
Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy

Case Application: Patients With EGFRm Resistance Post TKI and Platinum Chemotherapy

Tue 17 Dec 2024
COPD Care: Partnership Between Primary Care and Pulmonary Providers

COPD Care: Partnership Between Primary Care and Pulmonary Providers

CME credits: 0.25
Valid until: 16-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/copd-care-partnership-between-primary-care-and-pulmonary-providers/26927/

Primary care pro…

Mon 16 Dec 2024
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment

Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment

CME credits: 0.25
Valid until: 16-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/finally-i-can-take-a-break-from-my-itch-optimizing-ckd-ap-treatment/26639/

Patients with a…

Mon 16 Dec 2024
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)

Fri 13 Dec 2024
The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care

The Shifting ATTR-CM Landscape: Early Diagnosis, Emerging Therapies & Personalized Care

Fri 13 Dec 2024
Advances in IgAN Care From Kidney Week

Advances in IgAN Care From Kidney Week

CME credits: 0.25
Valid until: 13-12-2025
Claim your CME credit at https://reachmd.com/programs/cme/advances-in-igan-care-from-kidney-week/26628/

In this review of clinical trial results, ex…

Fri 13 Dec 2024
The Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer

The Weight of Recurrence: Navigating Multidisciplinary Care Planning in Recurring/Metastatic Cervical Cancer

Fri 06 Dec 2024
Advances in the Treatment and Management of MASH: More Options, More Decisions

Advances in the Treatment and Management of MASH: More Options, More Decisions

Wed 04 Dec 2024
Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC

Guidelines-recommended targeted therapies as second-line treatment options for patients with metastatic NSCLC

Wed 27 Nov 2024
Insights from global key opinion leaders on optimizing patient care in NSCLC

Insights from global key opinion leaders on optimizing patient care in NSCLC

Wed 27 Nov 2024
Application of guidelines-recommended broad molecular profiling to patients with NSCLC

Application of guidelines-recommended broad molecular profiling to patients with NSCLC

Wed 27 Nov 2024
Guideline recommendations for first-line treatment of advanced NSCLC with targeted therapies

Guideline recommendations for first-line treatment of advanced NSCLC with targeted therapies

Wed 27 Nov 2024
Incorporation of guidelines-concordant care for advanced NSCLC with second-line targeted therapies

Incorporation of guidelines-concordant care for advanced NSCLC with second-line targeted therapies

Wed 27 Nov 2024
Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC

Incorporation of guidelines-concordant immunotherapy in the perioperative setting of NSCLC

Wed 27 Nov 2024
Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings

Emerging and practice-changing directions in NSCLC within the perioperative and locally advanced settings

Wed 27 Nov 2024
Clinical evidence driving guidelines for immunotherapy in the neoadjuvant and adjuvant settings of NSCLC

Clinical evidence driving guidelines for immunotherapy in the neoadjuvant and adjuvant settings of NSCLC

Wed 27 Nov 2024
Guidelines-recommended first-line treatment with immunotherapy-based regimens in PD-L1- positive metastatic NSCLC

Guidelines-recommended first-line treatment with immunotherapy-based regimens in PD-L1- positive metastatic NSCLC

Wed 27 Nov 2024
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.